Nanobiotix Updates Share Capital and Voting Rights as of June 30, 2026
TipRanks (Fri, 31-Jul 5:27 PM ET)
Voting Rights and Shares Capital of the Company
Globe Newswire (Thu, 30-Jul 4:15 PM ET)
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
Globe Newswire (Tue, 2-Jun 4:30 PM ET)
Nanobiotix Joins the Euronext Tech Leaders Index
Globe Newswire (Tue, 2-Jun 2:30 AM ET)
NANOBIOTIX Announces Closing of Global Offering
Globe Newswire (Tue, 26-May 4:44 PM ET)
Globe Newswire (Fri, 22-May 4:15 PM ET)
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
Globe Newswire (Thu, 21-May 9:30 AM ET)
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
Globe Newswire (Thu, 21-May 2:30 AM ET)
Nanobiotix Announces Launch of Global Follow-On Offering
Globe Newswire (Wed, 20-May 6:19 PM ET)
Market Chameleon (Mon, 18-May 4:57 AM ET)
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Nanobiotix S.A. - Adss trades on the NASDAQ stock market under the symbol NBTX.
As of August 3, 2026, NBTX stock price climbed to $38.89 with 149,006 million shares trading.
NBTX has a beta of 0.29, meaning it tends to be less sensitive to market movements. NBTX has a correlation of 0.00 to the broad based SPY ETF.
NBTX has a market cap of $1.98 billion. This is considered a Small Cap stock.
In the last 3 years, NBTX traded as high as $57.14 and as low as $2.76.
The top ETF exchange traded funds that NBTX belongs to (by Net Assets): APIE.
NBTX has outperformed the market in the last year with a price return of +463.2% while the SPY ETF gained +21.1%. NBTX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +12.3% and +2.9%, respectively, while the SPY returned +5.7% and +1.9%, respectively.
NBTX support price is $36.33 and resistance is $40.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NBTX shares will trade within this expected range on the day.
